ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,600, issued on July 1, was assigned to ANIMA BIOTECH INC. (N.J.).

"c-Myc mRNA translation modulators and uses thereof in the treatment of cancer" was invented by David William Sheppard (Ramat Gan, Israel), Jason Paul Tierney (Ramat Gan, Israel), Aviad Mandabi (Ramat Gan, Israel), Iris Alroy (Ramat Gan, Israel), Rina Wassermann (Ramat Gan, Israel) and Yoni Sheinberger (Ramat Gan, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel c-Myc mRNA translation modulators, composition and methods of preparation CA thereof, and uses thereof in the treatment of cancer."

The patent was filed on March 15, 2023, under Appl...